Sales and Marketing

Showing 15 posts of 11524 posts found.

Lilly bolsters diabetes assets with $55m KeyBioscience deal

June 9, 2017 Medical Communications, Sales and Marketing Eli Lilly, KeyBiosciences

Eli Lilly has announced a strategic collaboration with KeyBioscience that sees the former company gain access to develop and commercialise …
artificial-intelligence-2228610_960_720

Data-driven insights: Keeping pace with the technological boom

June 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Data, data, technology

If you want to understand the importance of data, look at Google and Facebook – neither company is out of …
pfizer_sky

Pfizer gets fast-track approval for rare heart condition

June 8, 2017 Sales and Marketing Pfizer

Pfizer’s tafamidis has already been given approval in 40 countries across the globe but it has not currently broken into …
gavel-1017953_1280

Servier fights fine over antitrust breaches

June 7, 2017 Manufacturing and Production, Research and Development, Sales and Marketing European Commission, Servier, generic

Servier, a French pharmaceutical firm, has sought to lower the fine it received from the European Commission for breaching antitrust …

Novel Drug Movers and Shakers 2013-2016

June 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

To view the original whitepaper from NDA, please click here.Small and Medium Sized Companies in North America Lead Novel Drug …

Recipharm opens new GMP suite for clinical trial material

June 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Recipharm, the contract development and manufacturing organisation (CDMO), has opened a newly built GMP suite for clinical trial material (CTM) …
europe-1395916_640

New game, new rules: Pathways for better and affordable medicines in Europe

June 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, brexit, market access

Yannis Natsis, Policy Manager for Universal Access and Affordable Medicines at the European Public Health Alliance (EPHA), discusses the latest …

BMS’ Opdivo scores eighth approval in Europe for bladder cancer

June 5, 2017 Research and Development, Sales and Marketing Bristol-Myers Squibb, Cancer, Europe, European Commission, bladder cancer, immunotherapy

Bristol-Myers Squibb has announced that its flagship immunotherapy treatment Opdivo (nivolumab) has secured its eighth approval in Europe as the …

Merck KGaA signs potential $1 billion deal with UK biotech

June 5, 2017 Sales and Marketing F-star, Merck KGaA

UK biotech, F-Star, has scored a boost to its coffers with another link-up with a big pharma company, this time …
aging_-_hand

Latest prostate cancer research could provide boost for J&J

June 5, 2017 Research and Development, Sales and Marketing CRUK, Cancer, Johnson & Johnson, prostate cancer

Research funded by Cancer Research UK has found that abiraterone added to hormone therapy improved survival by over a third …
shutterstock_187433765

New targeted therapy promises strong response rate across 17 cancer types

June 5, 2017 Research and Development, Sales and Marketing ASCO, Cancer, Loxo Oncology, oncology

Loxo Oncology’s lead therapy larotrectinib made a big impact at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, …
ovarian_cancer

Breakthrough treatment for ovarian cancer displays promising results

June 5, 2017 Research and Development, Sales and Marketing Amgen, Cancer, ICR, ovarian cancer

A treatment that specifically targets ovarian cancer cells has shown that half of women who took the drug experienced shrinking …

Tau pathology as the key to understanding Alzheimer’s disease

June 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Alzheimer’s disease (AD) is a neurodegenerative disorder and the most common type of dementia (60–70%)[1], causing problems with memory, language, …
abbvie_uk_france

Abbvie names new General Managers for UK and France

June 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, appointment

Abbvie has announced a double appointment across its UK and French operations, naming Jérôme Bouyer as its UK General Manager, …
sara_rajeswaran_v2

ABPI appoints new Executive Director of Government Affairs

June 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI

The ABPI has moved to appoint Saratha Rajeswaran to the position of Executive Director of Government Affairs and Devolved Nations. …
The Gateway to Local Adoption Series

Latest content